Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Lapveteläinen T
The oral bioavailability of ABT-888 dihydrochloride is 56%-92% in mice
4-dihydroquinolin-5-yl)phosphonate
100 μM) shows inhibitroy effects on NO and PGE2 production in LPS-stimulated synovial fibroblasts
TraMetinib - CAS# 871700-17-3 0201 Lapveteläinen TTrametinib, also known as GSK1120212, CAS No. 871700 17 3, is a n orally bioavailable inhibitor of mitogen activated protein kinase kinase (MEK MAPK ERK kinase) with potential antineoplastic activity. Trametinib specifically binds to and inhibits MEK 1 and 2, resulting in an inhibition of growth factor mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual specificity threonine tyrosine kinases often upregulated in
US$ 450.00
US$ 1000.00
US$ 400.00
US$ 800.00
US$ 800.00
US$ 1250.00
US$ 800.00
US$ 375.00
US$ 800.00
US$ 500.00
US$ 1000.00
US$ 1400.00
US$ 1250.00
US$ 875.00
US$ 300.00
US$ 300.00
US$ 800.00
US$ 875.00